To further unravel the mechanism through which MELNs mitigate disease progression in T2DM mice, we generated an insulin-resistant hepatocyte model using Glucosamine (GlcN), a substance extensively utilized to simulate insulin resistance in cellular models [35, 36]. This evidence concerns the gene INS and type 2 diabetes mellitus.